#EASD26: Regeneron's antibody helps patients regain muscle after stopping GLP-1 therapy
MILAN — Regeneron’s investigational drug helped obesity patients who stopped taking Novo’s Wegovy regain a similar amount of muscle mass to what they lost when they took the GLP-1, according to new data from a mid-stage ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.